A subsequent study conducted by the same group [72] revealed that resveratrol/pterostilbene co-treatment was able to restore Estrogen Receptor-α (ERα) expression in ERα-negative breast cancer cells, characterized by a higher aggressivity and no response to conventional hormone-directed therapies. Here, ESR1 is linked to breast carcinoma.